HoxB1 inhibitors are a class of chemical compounds specifically designed to inhibit the activity of the HoxB1 protein, a member of the Hox family of transcription factors. These transcription factors are crucial in regulating the expression of genes involved in the development and patterning of the anterior-posterior axis during embryogenesis. HoxB1, in particular, plays a significant role in the formation of structures in the head and neck regions, and its precise regulation is essential for normal developmental processes. Inhibitors of HoxB1 are typically small molecules that bind to key regions of the protein, such as the DNA-binding homeodomain or other functional domains that are critical for its activity as a transcription factor. By binding to these regions, the inhibitors prevent HoxB1 from interacting with its target DNA sequences or from forming necessary protein-protein interactions, thus disrupting its ability to regulate gene expression.
The development of HoxB1 inhibitors involves a detailed understanding of the structural and functional aspects of the protein. Researchers often use techniques such as high-throughput screening to identify initial lead compounds that can effectively bind to HoxB1 and inhibit its function. These lead compounds are then optimized through structure-activity relationship (SAR) studies, which involve modifying the chemical structure to improve specificity, binding affinity, and stability. The chemical structures of HoxB1 inhibitors are diverse, typically featuring functional groups that facilitate strong interactions with the protein, such as hydrogen bonding, hydrophobic contacts, and van der Waals forces. Structural biology techniques like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are essential in visualizing these interactions at the atomic level, providing insights that guide the refinement of the inhibitors. Achieving high selectivity is a key objective in the design of HoxB1 inhibitors, as it ensures that these compounds specifically target HoxB1 without affecting other Hox proteins or unrelated transcription factors. This selectivity is crucial for enabling precise modulation of HoxB1 activity, allowing researchers to explore its specific role in developmental processes and its broader implications in gene regulation and cellular differentiation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can reactivate silenced genes. Might alter Hox gene expression by changing DNA methylation patterns. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase (HDAC) inhibitor. By altering histone acetylation, it can influence gene expression, potentially including Hox genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor known to affect gene expression, potentially impacting Hox genes. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Acts as an HDAC inhibitor and might influence Hox gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, it's a DNA methyltransferase inhibitor and can affect methylation-driven gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A signaling molecule that directly affects Hox gene expression during development. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
RXR agonist that might influence retinoic acid pathways and thereby impact Hox gene expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Aldehyde dehydrogenase inhibitor that might have indirect effects on Hox gene expression due to its impact on retinoic acid metabolism. | ||||||
all-trans Retinal | 116-31-4 | sc-210778A sc-210778 | 250 mg 1 g | $129.00 $379.00 | 7 | |
A form of vitamin A that could influence retinoic acid signaling and thus Hox gene expression. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
A synthetic retinoid that can impact retinoic acid pathways, potentially influencing Hox genes. | ||||||